Blend Labs Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
BLND$1.08+9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except per share amounts)
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $30,962 | $124,199 |
| Marketable securities and other investments | 105,960 | 229,948 |
| Trade and other receivables, net of allowance for credit losses of $149 and $436, respectively | 18,345 | 22,718 |
| Prepaid expenses and other current assets | 14,569 | 19,231 |
| Total current assets | 169,836 | 396,096 |
| Property and equipment, net | 3,945 | 5,742 |
| Operating lease right-of-use assets | 8,565 | 11,668 |
| Intangible assets, net | 2,108 | 2,127 |
| Deferred contract costs | 2,453 | 1,691 |
| Restricted cash, non-current | 7,291 | 5,358 |
| Other non-current assets | 11,867 | 10,082 |
| Total assets | $206,065 | $432,764 |
| Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,170 | $1,260 |
| Deferred revenue | 8,984 | 8,695 |
| Accrued compensation | 5,562 | 10,059 |
| Other current liabilities | 14,858 | 15,459 |
| Total current liabilities | 31,574 | 35,473 |
| Operating lease liabilities, non-current | 6,982 | 11,091 |
| Other non-current liabilities | 2,228 | 5,478 |
| Debt, non-current, net | 138,334 | 216,801 |
| Total liabilities | 179,118 | 268,843 |
| Commitments and contingencies (Note 8) | ||
| Redeemable noncontrolling interest | 46,190 | 40,749 |
| Stockholders’ equity: | ||
| Preferred stock, $0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of December 31, 2023; no shares authorized, issued and outstanding as of December 31, 2022 | — | — |
| Class A, Class B and Class C Common Stock, $0.00001 par value: 3,000,000 (Class A 1,800,000, Class B 600,000, Class C 600,000) shares authorized as of December 31, 2023; 249,910 (Class A 240,262, Class B 9,648, Class C 0) and 240,931 (Class A 230,210, Class B 10,721, Class C 0) shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 2 | 2 |
| Additional paid-in capital | 1,321,944 | 1,286,815 |
| Accumulated other comprehensive gain (loss) | 441 | (708) |
| Accumulated deficit | (1,341,630) | (1,162,937) |
| Total stockholders’ equity | (19,243) | 123,172 |
| Total liabilities, redeemable noncontrolling interest and stockholders’ equity | $206,065 | $432,764 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.